The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE President receives official welcome at Presidential Palace in Nicosia
Rain hits parts of UAE: Dubai Police issues public safety SMS alerts
UAE condemns terrorist shooting at Bondi Beach
UAE condemns shooting at Brown University in US
Sheikh Mohammed honours Palestinian architect with 'Great Arab Minds' award
Dubai's new road project to reduce travel time from 20 minutes to five
UAE, China foreign ministers affirm depth of Comprehensive Strategic Partnership
UAE relief teams conclude humanitarian mission in Sri Lanka
